Trial intelligence / Profile preview

Topical olive leaf extract vs topical acyclovir for facial herpes simplex

IRCT138808092652N1Phase 3Completed

Sponsor
Lorestan University of Medical Sciences
Start
Apr 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of olive leaf extract, aciclovir in herpes simplex (HSV), sponsored by Lorestan University of Medical Sciences. Started Apr 2009; status: completed.

02

Drugs

olive leaf extractaciclovir
03

Conditions

herpes simplex (HSV)

Beyond the preview

Go deeper on IRCT138808092652N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138808092652N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call